Dykstra: Doubleplay With GE and Sanofi

The stock hasn't been this low in almost four years. It's a Major League company and a great buy at this level. It has $48 billion in operating cash flow and $15 billion in the bank.

I am placing an order to buy 10 January 2009 $22.50 calls (VGEAX) at $8.70 or better.

My second play is Sanofi-Aventis(SNY Quote) today. I'll keep it short and sweet.

Shares of the healthcare research and development company are trading near their lowest point in the last year. The stock closed at $37.17 on Wednesday, just a couple of bucks above the bottom of its 52-week range of $35.06 - $49.04.

It released some bad, but not unexpected news yesterday when it said its cancer drug, Aflibercept, failed to achieve its goal in a recent study. However, I like this company and think it'll pump out a win.

The specifics: I'm going to buy 10 January $30 calls (OYCAF) at $8.20 or better. Don't forget that if either of these orders is filled, I will place a good-till-cancel (GTC) sell order $1.00 above the fill price.

Always Remember: Life is a journey, enjoy the ride!